Trial intelligence / Profile preview

Prophylactic Antibiotic Treatment in Hemodialysis Patients with Central Venous Catheters

2020-001033-12Phase 4Active

Sponsor
Niels Eske Bruun
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of amoxicillin + clavulanate in bloodstream infection (BSI), Infection and bacterial disease (2 arms), sponsored by Niels Eske Bruun. Primary endpoints: Hospitalization for bloodstream infection and Severe blood culture–negative infection. Started Apr 2020; status: active.

02

Drugs

amoxicillin + clavulanate
03

Conditions

bloodstream infection (BSI)Infectionbacterial disease

Beyond the preview

Go deeper on 2020-001033-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-001033-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call